All the Active Ingredient Drugs
LMWH. Dalteparin 25000 IU/ml. SINGLE DOSE SYRINGE: 2,500 IU/ml x 0.2/0.3/0.4/0.5/.0.6/0.72 ml
Once dly admin.: 200 IU/kg bdy. wt. is admin. SC once dly. Monitor. of the anticoagul. effect is not necessary. The single daily dose should not exceed 18000 IU.
Twice dly. admin.: Alternatively, a dose of 100 IU/kg total bdy. wt. admin. SC twice dly. may be given. Monitor.of the anticoag.effect is generally not necessary but should be consid. for specific pt. populations. Max. plasma levels are obtained 3-4 hrs. after SC inj. when samples should be taken. Recommended plasma levels are between 0.5-1.0 IU anti-Xa/ml. See lit.
Prevent. clot during hemodialysis
hemofiltration in acute renal fail. or
chron. renal insuffic., tmt. acute deep
venous pulm. embol., proph.
thromboembol. in pre and post op. surg.,
unstable coron. art. dis. See lit.
C/I: Pts. with active major bleed.
Pts. with a history of heparin induced thrombocytop. or heparin induced thrombocytop. with thrombosis.
Pts. with prior hypersens. to dalteparin sodium (e.g., pruritis, rash, anaph. react.).
Pts. undergoing Epidural/Neuraxial anesthesia , As a tmt. for unstable angina and non-Q-wave MI, for prolong. VTE prophylax.
Pts. with prior hypersens. to heparin or pork products.
